1197680

Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany — FEI 2211084

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Whippany, NJ (United States)